Vitiligo Gets Long-Missing Definitions for Severity and Relapse - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Vitiligo Gets Long-Missing Definitions for Severity and Relapse

A new international consensus framework standardizes how disease severity and relapse are defined, addressing inconsistencies that have complicated clinical trials and treatment decisions.

  • By

  • Kerri Miller

  • April 15, 2026

  • 2 min

Share

  • 1

    Vitiligo lacks standardized definitions of severity and relapse, complicating treatment strategies and patient management.

  • 2

    Recent therapeutic advances, including JAK inhibitors, have not been adequately assessed for relapse due to inconsistent definitions.

  • 3

    An international consensus statement aims to establish body surface area-based severity strata and define relapse more clearly.

  • 4

    The new framework represents a shift towards multidimensional assessments, incorporating both psychological and clinical factors.

  • 5

    Applying the consensus criteria consistently in clinical trials and practice is the next challenge for managing vitiligo.

Original Source(s)

Vitiligo Gets Long-Missing Definitions for Severity and Relapse

  • by Kerri Miller

  • April 15, 2026

Related Content

A Systematic Review of Electrochemotherapy Applications in Pediatric Patients

CDC Lists Dozens of Infectious Disease Tests as Unavailable

More than two dozen assays paused or discontinued, with alternative testing options noted

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.